---
title: "GLP-1 ଇଞ୍ଜେକ୍ସନ: ଭାରତରେ ସାପ୍ତାହିକ କଲମକୁ କିପରି ସୁରକ୍ଷିତ ଭାବରେ ବ୍ୟବହାର କରିବେ |"
description: "ଭାରତରେ GLP-1 ରିସେପ୍ଟର ଆଗୋନିଷ୍ଟ ଇଞ୍ଜେକ୍ସନ୍ ପେନ୍ ବ୍ୟବହାର କରିବା ପାଇଁ ଷ୍ଟେପ୍-ଷ୍ଟେପ୍ ଗାଇଡ୍ - ଷ୍ଟୋରେଜ୍, ଇଞ୍ଜେକ୍ସନ୍ କ techni ଶଳ, ଘୂର୍ଣ୍ଣନ ସ୍ଥାନ, ନିଷ୍କାସନ ଏବଂ ସାଧାରଣ ତ୍ରୁଟିକୁ ଏଡାଇବା ପାଇଁ |"
canonical: "https://www.kesho.health/or/blog/glp-1-injection-how-to-use"
markdown_url: "https://www.kesho.health/md/or/blog/glp-1-injection-how-to-use"
date_published: "Jun 15, 2026"
date_modified: "Jun 26, 2026"
author: "Dr. Ananya Mehta"
language: "or-IN"
primary_keyword: "GLP-1 injection how to use"
---

# GLP-1 ଇଞ୍ଜେକ୍ସନ: ଭାରତରେ ସାପ୍ତାହିକ କଲମକୁ କିପରି ସୁରକ୍ଷିତ ଭାବରେ ବ୍ୟବହାର କରିବେ |

> **Short answer:** GLP-1 ରିସେପ୍ଟର ଆଗୋନିଷ୍ଟ ଇଞ୍ଜେକ୍ସନ ସାଧାରଣତ weekly ପୂର୍ବରୁ ପୂର୍ଣ୍ଣ ପେନ୍ ଉପକରଣ ବ୍ୟବହାର କରି ପେଟ, ଜଙ୍ଘ କିମ୍ବା ଉପର ବାହୁରେ ସାପ୍ତାହିକ ଥରେ ଥରେ ଦିଆଯାଏ | ପ୍ରଥମ ବ୍ୟବହାର ପୂର୍ବରୁ କଲମଗୁଡିକ ରେଫ୍ରିଜରେଜେସନ୍, ଉପଯୁକ୍ତ ହାତର ସ୍ୱଚ୍ଛତା, ସାଇଟ୍ ଘୂର୍ଣ୍ଣନ, ଏବଂ ସ୍ଥାନୀୟ ନିୟମ ଅନୁଯାୟୀ ତୀକ୍ଷ୍ଣ ନିଷ୍କାସନ ଆବଶ୍ୟକ କରେ | ସର୍ବଦା ତୁମର ଡାକ୍ତରଙ୍କ ଟାଇଟ୍ରେସନ୍ କାର୍ଯ୍ୟସୂଚୀ ଏବଂ ଉତ୍ପାଦ ଲେବଲ୍ ଅନୁସରଣ କର | Kesho କେବଳ ଶିକ୍ଷିତ - ଆମେ ବ୍ୟକ୍ତିଗତ ଉପକରଣ ତାଲିମ ଲେଖିବା କିମ୍ବା ପ୍ରଦର୍ଶନ କରିବା ନାହିଁ |

**Canonical HTML:** https://www.kesho.health/or/blog/glp-1-injection-how-to-use  
**Markdown:** https://www.kesho.health/md/or/blog/glp-1-injection-how-to-use


*ସାପ୍ତାହିକ ଇଞ୍ଜେକ୍ସନ୍ ପେନ୍ ହେଉଛି ଅଧିକାଂଶ ଭାରତୀୟ ରୋଗୀ କିପରି semaglutide, dulaglutide, tirzepatide, ଏବଂ ଅନ୍ୟାନ୍ୟ ⟦3 ରିସେପ୍ଟର ଆଗୋନିଷ୍ଟ ଗ୍ରହଣ କରନ୍ତି | ସଠିକ୍ କ techni ଶଳ ଆରାମରେ ଉନ୍ନତି ଆଣେ, ସାଇଟ୍ ପ୍ରତିକ୍ରିୟାକୁ ହ୍ରାସ କରେ, ଏବଂ ication ଷଧର ଶକ୍ତି ରକ୍ଷା କରେ - ବିଶେଷତ homes ଯେଉଁ ଘରେ ରେଫ୍ରିଜରେଜେସନ୍ ଏବଂ ତୀକ୍ଷ୍ଣ ନିଷ୍କାସନ ଯୋଜନା ଆବଶ୍ୟକ କରେ |*

*Reviewed by Dr. Ananya Mehta, MD, DM Endocrinology. This article has been reviewed by our medical advisory team, including endocrinologists, internal medicine specialists, and cardiologists, and is based on current scientific evidence and Indian clinical guidelines. Last reviewed: June 2026.*

## Key takeaways

- Weekly GLP-1 RA pens are injected subcutaneously—not into muscle or vein—with technique taught by your doctor or pharmacist.
- Cold-chain storage (2°C–8°C) before first use is critical; after opening, most pens tolerate room temperature below 30°C for several weeks.
- Rotate injection sites weekly to reduce skin reactions and lipodystrophy.
- Never share pens, reuse needles, or use expired or improperly stored devices.
- Schedule injections on the same day each week and set reminders during dose titration phases.


## At a glance (India)

| Field | Value |
| --- | --- |
| Typical frequency | Once weekly (most injectable GLP-1 RAs) |
| Injection sites | Abdomen, thigh, or upper arm (subcutaneous) |
| Storage before use | 2°C–8°C refrigerated |
| Prescription status | Schedule H—India |


## In this article

- Before your first injection
- Storage and cold-chain rules
- Preparing the pen
- Injection technique step by step
- Site rotation and skin care
- Dose titration schedules
- Sharps disposal in India
- Common mistakes to avoid


## Before your first injection

Your first GLP-1 receptor agonist injection should ideally occur after hands-on training from your doctor, nurse, or pharmacist. Different pen devices—used across the semaglutide, dulaglutide, liraglutide, and tirzepatide drug class—have slightly different button mechanisms, dose windows, and priming steps. Read the patient information leaflet in your CDSCO-approved packaging even if you have watched online videos; device designs change between manufacturers. Confirm your prescription strength matches the pen label (for example, 0.25 mg titration dose versus 0.5 mg or 1 mg maintenance). Set a recurring weekly reminder on the same day and time—consistency supports steady drug levels and helps you notice side-effect patterns. Keep a simple log: date, site used, dose, and any nausea or injection-site reaction. Bring this log to follow-up visits during titration.

> **Subcutaneous injection:** An injection into the fatty tissue just beneath the skin—not into muscle or a blood vessel—used for most GLP-1 receptor agonist pens.

## Storage and cold-chain rules in Indian homes

Injectable GLP-1 RAs require refrigeration between 2°C and 8°C before first use. Store pens in the main refrigerator compartment—not the freezer door where temperatures fluctuate. During summer load-shedding or travel, use insulated bags with ice packs validated for medicine transport; avoid leaving pens in a hot car. After first use, most weekly pens may be kept at room temperature below 30°C for a defined period per manufacturer label—often four to six weeks. Protect from direct sunlight and heat. Never freeze a pen; discard if frozen. Oral semaglutide tablets follow different storage rules and are not covered in this injection guide. When purchasing from a pharmacy, confirm the pen arrived cold; room-temperature shipped injectables from unverified sellers are a safety concern.

## Preparing the pen

Wash hands with soap and water. Remove the pen from the refrigerator and let it sit at room temperature for 15–30 minutes if cold injections cause discomfort—check your specific product leaflet. Inspect the pen: clear colourless to slightly yellow solution without particles or cloudiness. Attach a new sterile needle if your device requires separate needles; some pens come with built-in hidden needles. Prime the pen if instructed—this expels air and ensures full dose delivery. Select an injection site: abdomen at least five centimetres from the navel, front of thigh, or back of upper arm (may need assistance). Avoid scars, moles, bruises, or areas of lipodystrophy from repeated injections at the same spot.

## Injection technique step by step

Clean the site with an alcohol swab if available and let dry. Pinch a fold of skin gently. Insert the needle at a 90-degree angle for most patients; very lean individuals may use 45 degrees per training. Press the injection button fully and hold per device instructions—often five to ten seconds—to deliver the complete dose. Withdraw the needle and release the skin pinch. Do not rub the site aggressively; light pressure with a cotton swab is sufficient. Immediately dispose of the needle in a sharps container. Never recap needles by hand. If blood appears, apply gentle pressure—this is usually harmless. If you are unsure the full dose was delivered, do not repeat the injection without medical advice; contact your care team. For upper-arm injections, ask a family member for assistance to ensure proper angle and visibility.

## Site rotation and skin care

Rotate injection sites each week: if you used the right abdomen last week, choose left thigh or alternate abdomen quadrant this week. Rotation reduces lipodystrophy—fatty lumps under the skin that can affect absorption—and minimises local itching or redness. Mild injection-site reactions are uncommon with weekly GLP-1 pens but possible. Persistent nodules, severe pain, or signs of infection require medical review. Avoid injecting through clothing. Loose comfortable clothing helps after abdominal injections, especially for patients who wear sarees or tight waistbands. Moisturise skin generally but not immediately on the injection site before needling.

> **TIP:** Pair your weekly injection with a recurring phone alarm labelled with dose strength during titration. Note any nausea in the next 24–48 hours to discuss at follow-up.

## Understanding dose titration schedules

GLP-1 receptor agonists are started at low doses and increased every four weeks or per your physician's plan. Semaglutide weekly injection commonly begins at 0.25 mg for four weeks, then 0.5 mg, with further increases to 1 mg or 2 mg depending on indication and tolerance. Tirzepatide and dulaglutide follow their own labelled titration pathways. Do not skip ahead to higher doses because of impatience—rapid escalation increases nausea risk without improving long-term outcomes. If you miss a weekly dose within a defined window, product labels specify whether to take promptly or wait until the next scheduled day; do not double doses. Oral semaglutide uses daily titration and is a separate regimen. Your diabetologist adjusts the schedule based on HbA1c, weight response, and side effects.

## Sharps disposal in India

Used needles and pens belong in puncture-resistant sharps containers—not household dustbins where waste workers risk injury. Many hospital pharmacies and diabetes clinics accept filled containers. Some municipalities have biomedical waste collection points; rules vary by city. Never flush needles. If travelling within India, carry a portable sharps case. Kesho's waste disposal article covers regulatory context in more detail. Teaching family members safe handling prevents accidental needle sticks at home. Apartment housing societies in metros may issue biomedical waste guidelines—check with your building manager rather than discarding pens in general dry waste.

## Common mistakes to avoid

Sharing pens between family members—even if both have diabetes—is unsafe due to infection risk and wrong dosing. Reusing needles blunts tips, increases pain, and raises infection risk. Injecting intramuscularly by mistake may alter absorption. Using expired pens or pens left unrefrigerated for extended periods compromises potency. Buying pens without prescription from social-media sellers bypasses cold-chain assurance. Stopping injections abruptly without medical guidance may cause glycaemic rebound. If injection phobia is a barrier, discuss oral semaglutide or counselling with your doctor—never abandon therapy silently.

## When to contact your care team after injection

Contact your doctor the same day for spreading warmth, pus, fever, or severe pain suggesting infection. Report persistent nausea preventing fluids for more than twenty-four hours, especially during heat waves. Sudden allergic symptoms—lip swelling, breathing difficulty, widespread rash—require emergency care. If you suspect a partial dose or device malfunction, document the pen counter reading and call your clinic rather than guessing a supplemental dose. Transplant recipients, pregnant patients planning therapy cessation, and elderly frail individuals should have lower thresholds for early contact. Caregivers administering upper-arm injections should be trained to recognise these warning signs when patients feel unwell after self-injecting.

## First-month confidence building

Injection anxiety is normal among Indian patients new to self-injectable therapy. Practise pen handling with cap on before first dose. Inject at the same time weekly—Sunday morning before breakfast works for many families. Pair injection with a habit you already have: after brushing teeth, before Sunday video call with parents. If blood appears at the site, apply gentle pressure with cotton; small bleeds are common and not dangerous. Bruises fade with site rotation. Confidence grows by week three for most patients. If phobia persists, oral semaglutide or nurse-administered clinic injections may be alternatives—discuss with your doctor rather than skipping doses silently.

## Generic pen device differences

CDSCO-approved generic semaglutide pens may use different click mechanisms, dose counters, or needle attachment systems than innovator devices you saw in tutorials. When your pharmacy switches manufacturers after hospital tender changes, ask for a sixty-second device demonstration at the counter. Never assume identical technique across brands. Keep patient leaflets for each manufacturer in your medicine folder. Device confusion is a common cause of partial dosing and perceived treatment failure in the first month after generic switches.

## Rotating sites over months of therapy

Maintain a simple paper diagram marking abdomen quadrants and thighs used each week. Reusing same two-centimetre zone causes lipohypertrophy and erratic absorption. After six months many patients forget rotation discipline—review technique at follow-up. Scar tissue from old sites feels lumpy; move to fresh area and mention at next visit.

## Frequently asked questions

### Does the GLP-1 injection hurt?

Most patients describe a brief pinch. Using room-temperature pens, new needles, and relaxed skin reduces discomfort. Fear of needles is valid—discuss alternatives with your doctor.

### Can I inject GLP-1 into my arm by myself?

Upper-arm injection is possible but often easier with assistance. Abdomen and thigh are common self-injection sites.

### What if I see air bubbles in the pen?

Small air bubbles are common. Priming steps remove air before the therapeutic dose. Follow your device leaflet; do not attempt to modify the pen mechanism.

### Can I travel on domestic flights with GLP-1 pens?

Yes, with prescription documentation and insulated carry bags. Keep pens in cabin baggage, not checked luggage exposed to freezing cargo holds.

### How soon after injection might nausea start?

Some patients notice gastrointestinal effects within 24–72 hours after dose increases, especially during titration. Eating lighter meals helps.

### Is daily liraglutide different from weekly pens?

Yes. Liraglutide in the GLP-1 RA class is typically injected daily with its own device and titration schedule. Confirm frequency with your prescription label.

## People also ask

### Where is the best place to inject GLP-1?

Abdomen, thigh, and upper arm are approved subcutaneous sites. Rotate weekly and avoid scars or bruised skin.

### Do GLP-1 pens need to be refrigerated?

Yes, before first use at 2°C–8°C. After opening, most weekly pens allow room temperature below 30°C for several weeks per label.

### What happens if I miss a weekly GLP-1 dose?

Follow your specific product label and call your doctor. Do not double doses without medical guidance.

### Can I inject GLP-1 at night?

You may inject any time of day if you stay consistent weekly. Some patients prefer evenings if nausea affects morning appetite.

### How do I know the injection worked?

Pens click or show dose counters when complete. Hold the button for the full time specified in your leaflet.

### Can children use GLP-1 injections?

Paediatric indications vary by molecule and are limited. Adult GLP-1 RA use in India follows labelled indications and specialist oversight for adolescents if applicable.

## References

1. [RSSDI Clinical Practice Recommendations for Management of Type 2 Diabetes Mellitus (2023).](https://rssdi.in/)
2. [American Diabetes Association Standards of Care in Diabetes—Pharmacologic Approaches (2024).](https://pubmed.ncbi.nlm.nih.gov/38078554/)
3. [CDSCO Guidelines on Storage and Handling of Biological Products.](https://cdsco.gov.in/)
4. [Biomedical Waste Management Rules, 2016 (India). Ministry of Environment, Forest and Climate Change.](https://cpcb.nic.in/)


## Related guides

- [semaglutide-india-complete-guide](https://www.kesho.health/blog/semaglutide-india-complete-guide) · [MD](https://www.kesho.health/md/blog/semaglutide-india-complete-guide)
- [glp-1-waste-disposal-india](https://www.kesho.health/blog/glp-1-waste-disposal-india) · [MD](https://www.kesho.health/md/blog/glp-1-waste-disposal-india)
- [glp-1-travel-india](https://www.kesho.health/blog/glp-1-travel-india) · [MD](https://www.kesho.health/md/blog/glp-1-travel-india)
- [oral-semaglutide-india-what-to-know](https://www.kesho.health/blog/oral-semaglutide-india-what-to-know) · [MD](https://www.kesho.health/md/blog/oral-semaglutide-india-what-to-know)


---
*Kesho provides GLP-1 education only. We do not prescribe or sell medications. [Editorial policy](https://www.kesho.health/editorial-policy).*